Highest-materiality recent filing
Silicon Labs Q2 revenue $228M (+18% YoY); non-GAAP EPS $0.71, up 545%
Revenue $228M, up 18% YoY; Industrial & Commercial $135M (+23%), Home & Life $93M (+12%).
Silicon Labs and Texas Instruments: HSR waiting period expires, deal moves forward
HSR Act waiting period expired May 22, 2026, satisfying one condition to close merger with Texas Instruments.
Silicon Labs Q1 revenue $214M (+20% YoY); non-GAAP EPS $0.53; guidance suspended due to TI merger
Revenue $214M, up 20% YoY; Industrial & Commercial up 33% to $128M, Home & Life up 5% to $86M.
Silicon Labs shareholders approve merger with Texas Instruments
Over 99.9% of votes cast approved adoption of Merger Agreement with Texas Instruments (25,878,105 for, 7,467 against).
Silicon Labs reports FY 2025 revenue $785M (+34% YoY); GAAP EPS $(1.98); Q4 rev $208M (+25%)
Full-year revenue $785M, up 34% YoY; Industrial & Commercial $445M (+31%), Home & Life $340M (+38%).
Texas Instruments to acquire Silicon Labs for $231 per share in cash
Purchase price of $231.00 per share in cash; total equity value approximately $7.2 billion.
Silicon Labs Q3 revenue $206M, non-GAAP EPS $0.32; guides Q4 rev $200-215M
Revenue $206M; Industrial & Commercial $118M (+22% YoY), Home & Life $88M (+26% YoY).
Silicon Labs Q2 revenue $193M (+33% YoY); guides Q3 $200-210M with non-GAAP EPS $0.20-0.40
Revenue $193M (+33% YoY, +9% QoQ). Industrial & Commercial $110M (+25%), Home & Life $83M (+45%).
Silicon Labs Q1 revenue $178M (+47% YoY); guides Q2 $185-200M with narrowing loss
GAAP operating loss $32M, diluted EPS -$0.94; non-GAAP operating loss $7M, EPS -$0.08.
Audit Committee dismissed Ernst & Young as independent auditor on March 3, 2025, and appointed Deloitte & Touche for fiscal year ending Jan 3, 2026.
Silicon Labs Q4 revenue $166M, nearly doubles YoY; guides Q1 $170-185M
Q4 GAAP diluted EPS loss $(0.73); non-GAAP diluted EPS loss $(0.11).
Silicon Labs Q3 revenue $166M, GAAP EPS $(0.88); guides Q4 revenue $161-171M
Revenue $166M; GAAP operating loss $30M; GAAP diluted loss per share $(0.88).
Silicon Labs Q2 revenue $145M; GAAP EPS loss $(2.56); Q3 guidance $160-170M
GAAP operating loss $48M; GAAP diluted EPS loss $(2.56).
Silicon Labs Q1 revenue $106M, GAAP EPS -$1.77; Q2 outlook $135-145M
Revenue $106M, GAAP gross margin 52%, GAAP operating loss $59M, GAAP diluted EPS $(1.77).
Silicon Labs appoints Dean Butler as CFO, effective May 15, 2024
Dean Butler joins from Synaptics (Senior VP & CFO since Oct 2019); replaces interim CFO Mark Mauldin.
Silicon Labs Q4 revenue $87M, GAAP loss $2.19/share; material weakness; Q1 guidance $100-110M
Revenue $87M, GAAP diluted loss per share $(2.19); non-GAAP loss $(1.19).
Silicon Labs CFO John Hollister to depart Feb 2, 2024; CAO Mauldin named interim CFO
John Hollister resigns as CFO effective Feb 2, 2024, to become CFO of partner GlobalFoundries.
Silicon Labs Q3 revenue $204M, guides Q4 $70-100M; non-GAAP EPS $0.62
GAAP diluted EPS $0.32; non-GAAP diluted EPS $0.62.
Silicon Labs Q2 revenue $245M; Q3 guidance $190-210M, non-GAAP EPS $0.45-$0.73
Revenue $245M (in-line); Industrial & Commercial record $165M, Home & Life $80M (decline).
Silicon Labs completes conversion of $533.6M convertible notes, issues 919,897 shares
Holders converted 99.74% of $533.6M principal outstanding of 0.625% convertible notes due 2025.
Silicon Labs Q1 revenue $247M (+6% YoY); Q2 guidance $238-248M
Revenue $247M (+6% YoY); GAAP diluted EPS $0.41; non-GAAP diluted EPS $1.12.
Silicon Labs calls all outstanding 0.625% Convertible Notes due 2025 for redemption on June 20, 2023
Redemption price: 100% of principal plus accrued interest; conversion deadline June 16, 2023.
Silicon Labs Q4 revenue $257M (+23% YoY); non-GAAP EPS $1.31, full-year revenue tops $1B
Q4 revenue $257M exceeded guidance top end; Industrial & Commercial revenue up 36% YoY to $157M.
Silicon Labs Q3 revenue $270M (+46% YoY); guides Q4 revenue $245-255M
GAAP diluted EPS $0.60; non-GAAP diluted EPS $1.21.
Silicon Labs Q2 revenue $263M, up 55% YoY; guides Q3 revenue $265-275M
Revenue $263M, up 55% YoY and 13% sequentially; GAAP EPS $0.60, non-GAAP EPS $1.17.
Silicon Labs Q1 revenue $234M (+48% YoY); guides Q2 revenue $245-255M
Revenue $234M, up 12% sequential, 48% YoY; GAAP EPS $0.58, non-GAAP EPS $1.05.
Silicon Labs Q4 record revenue $209M (+43% YoY); Q1 guidance $220-230M, non-GAAP EPS $0.58-0.68
Revenue $209M, up 13% sequentially and 43% YoY, above guidance range high end.
Silicon Labs discloses CEO Matt Johnson's compensation: $650K base, 130% bonus target, 25K PSUs
Annual base salary $650,000 effective Jan 2, 2022, with target bonus of 130% of base.
Silicon Labs reports record IoT revenue of $185M in Q3; guides Q4 above
Revenue $185M (up 39% YoY) beat guidance; GAAP diluted loss per share $(0.45); non-GAAP EPS $0.34.
Silicon Labs Q2 revenue $278M record; IoT $169M record; completes I&A sale to Skyworks for $2.75B
Revenue $278M (record, above guidance); IoT revenue $169M (+7% seq, +48% YoY).
As of the Effective Date, Sandeep Kumar will cease serving as Senior Vice President of Worldwide Operations and will serve in a non-executive advisory role.
On April 18, 2024, Robert Conrad notified the Company of his decision to resign from the Company’s Board of Directors effective upon his commencement of employment as Senior Vice President of Worldwide Operations.
On April 24, 2024, Silicon Laboratories Inc. (“Silicon Laboratories” or the “Company”) announced the appointment of Robert Conrad as Senior Vice President of Worldwide Operations, effective April 29, 2024 (the “Effective Date”).
As of the Effective Date, Mark Mauldin will cease serving as Interim Chief Financial Officer and will continue to serve in his role as Chief Accounting Officer.
On February 27, 2024, Silicon Laboratories Inc. (the “Company”) announced the appointment of Dean Butler as Senior Vice President and Chief Financial Officer, effective May 15, 2024
The Company appointed Mark Mauldin, the Company’s Chief Accounting Officer, to serve as the Company’s interim Chief Financial Officer beginning on February 2, 2024.
the Company expects to appoint Mark Mauldin, the Company’s Chief Accounting Officer, to serve as the Company’s interim Chief Financial Officer.
On December 5, 2023, John Hollister, the Chief Financial Officer and Senior Vice President of Silicon Laboratories Inc. (the “Company”), delivered his notice of resignation to be effective as of February 2, 2024
On July 21, 2022, William Wood notified Silicon Laboratories Inc. (“Silicon Laboratories” or the “Company”) of his decision to not stand for re-election at the Company’s 2023 annual meeting of stockholders.
On July 21, 2022, Silicon Laboratories appointed Robert Conrad, age 62, as a member of its board of directors to serve as a Class I director effective immediately.
On December 31, 2021, Silicon Laboratories appointed Sherri Luther as a member of its board of directors to serve as a Class III director effective as of January 2, 2022.
Mr. Johnson was appointed to the Company’s board of directors effective as of January 2, 2022 and will serve as a Class II director with a term expiring in 2024.
Max materiality 1.00 · Median 0.62 · Most common event earnings